Dopamine Receptor Blockade Attenuates Purinergic P2X4 Receptor-Mediated Prepulse Inhibition Deficits and Underlying Molecular Mechanisms

Overview

Journal Front Cell Neurosci

Specialty Cell Biology

Date 2019 Aug 10

PMID 31396053

Citations 9

Authors

Sheraz Khoja

Liana Asatryan

Michael W Jakowec

Daryl L Davies

Affiliations

Soon will be listed here.

Abstract

Sensorimotor gating refers to the ability to filter incoming sensory information in a stimulus-laden environment and disruption of this physiological process has been documented in psychiatric disorders characterized by cognitive aberrations. The effectiveness of current pharmacotherapies for treatment of sensorimotor gating deficits in the patient population still remains controversial. These challenges emphasize the need to better understand the biological underpinnings of sensorimotor gating which could lead to discovery of novel drug targets for therapeutic intervention. Notably, we recently reported a role for purinergic P2X4 receptors (P2X4Rs) in regulation of sensorimotor gating using prepulse inhibition (PPI) of acoustic startle reflex. P2X4Rs are ion channels gated by adenosine-5'-triphosphate (ATP). Ivermectin (IVM) induced PPI deficits in C57BL/6J mice in a P2X4R-specific manner. Furthermore, mice deficient in P2X4Rs [P2X4R knockout (KO)] exhibited PPI deficits that were alleviated by dopamine (DA) receptor antagonists demonstrating an interaction between P2X4Rs and DA receptors in PPI regulation. On the basis of these findings, we hypothesized that increased DA neurotransmission underlies IVM-mediated PPI deficits. To test this hypothesis, we measured the effects of D1 and D2 receptor antagonists, SCH 23390 and raclopride respectively and D1 agonist, SKF 82958 on IVM-mediated PPI deficits. To gain mechanistic insights, we investigated the interaction between IVM and dopaminergic drugs on signaling molecules linked to PPI regulation in the ventral striatum. SCH 23390 significantly attenuated the PPI disruptive effects of IVM to a much greater degree than that of raclopride. SKF 82958 failed to potentiate IVM-mediated PPI disruption. At the molecular level, modulation of D1 receptors altered IVM's effects on dopamine and cyclic-AMP regulated phosphoprotein of 32 kDa (DARPP-32) phosphorylation. Additionally, IVM interacted with the DA receptors antagonists and SKF 82958 in phosphorylation of Ca/calmodulin kinase IIα (CaMKIIα) and its downstream target, neuronal nitric oxide synthase (nNOS). Current findings suggest an involvement for D1 and D2 receptors in IVM-mediated PPI disruption via modulation of DARPP-32, CaMKIIα and nNOS. Taken together, the findings suggest that stimulation of P2X4Rs can lead to DA hyperactivity and disruption of information processing, implicating P2X4Rs as a novel drug target for treatment of psychiatric disorders characterized by sensorimotor gating deficits.

Citing Articles

Ivermectin increases striatal cholinergic activity to facilitate dopamine terminal function.

Wadsworth H, Warnecke A, Barlow J, Robinson J, Steimle E, Ronstrom J Cell Biosci. 2024; 14(1):50.

PMID: 38632622 PMC: 11025261. DOI: 10.1186/s13578-024-01228-2.

The neurobiological mechanisms and therapeutic prospect of extracellular ATP in depression.

Wang K, Huang S, Fu D, Yang X, Ma L, Zhang T CNS Neurosci Ther. 2024; 30(2):e14536.

PMID: 38375982 PMC: 10877668. DOI: 10.1111/cns.14536.

Short- and long-term administration of buprenorphine improved gene expression of PX and GABAA receptors in the hippocampus of methamphetamine rats.

Roshani S, Hatami Nemati H, Sadeghian R, Khoshsirat H Heliyon. 2022; 8(11):e11432.

PMID: 36444255 PMC: 9699974. DOI: 10.1016/j.heliyon.2022.e11432.

Altered purinergic receptor expression in the frontal cortex in schizophrenia.

Alnafisah R, Lundh A, Asah S, Hoeflinger J, Wolfinger A, Hamoud A Schizophrenia (Heidelb). 2022; 8(1):96.

PMID: 36376358 PMC: 9663420. DOI: 10.1038/s41537-022-00312-1.

Duration of Social Isolation Affects Production of Nitric Oxide in the Rat Brain.

Vrankova S, Galandakova Z, Benko J, Cebova M, Riecansky I, Pechanova O Int J Mol Sci. 2021; 22(19).

PMID: 34638682 PMC: 8509065. DOI: 10.3390/ijms221910340.

References

Braff D, Swerdlow N, Geyer M . Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry. 1999; 156(4):596-602. DOI: 10.1176/ajp.156.4.596. View

Ralph R, Varty G, Kelly M, Wang Y, Caron M, Rubinstein M . The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci. 1999; 19(11):4627-33. PMC: 6782596. View

Hayashi Y, Nishio M, Naito Y, Yokokura H, Nimura Y, Hidaka H . Regulation of neuronal nitric-oxide synthase by calmodulin kinases. J Biol Chem. 1999; 274(29):20597-602. DOI: 10.1074/jbc.274.29.20597. View

Kumari V, Soni W, Sharma T . Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry. 1999; 156(7):1046-51. DOI: 10.1176/ajp.156.7.1046. View

Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm B . Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A. 2000; 97(4):1856-60. PMC: 26526. DOI: 10.1073/pnas.97.4.1856. View

Swerdlow N, Martinez Z, Hanlon F, Platten A, Farid M, Auerbach P . Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci. 2000; 20(11):4325-36. PMC: 6772622. View

Suemaru J, Akiyama K, Tanabe Y, Kuroda S . Methamphetamine decreases calcium-calmodulin dependent protein kinase II activity in discrete rat brain regions. Synapse. 2000; 36(3):155-66. DOI: 10.1002/(SICI)1098-2396(20000601)36:3<155::AID-SYN1>3.0.CO;2-N. View

Kumari V, Soni W, Mathew V, Sharma T . Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication. Arch Gen Psychiatry. 2000; 57(6):609-14. DOI: 10.1001/archpsyc.57.6.609. View

Komeima K, Hayashi Y, Naito Y, Watanabe Y . Inhibition of neuronal nitric-oxide synthase by calcium/ calmodulin-dependent protein kinase IIalpha through Ser847 phosphorylation in NG108-15 neuronal cells. J Biol Chem. 2000; 275(36):28139-43. DOI: 10.1074/jbc.M003198200. View

10.

Ralph R, Paulus M, Fumagalli F, Caron M, Geyer M . Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. J Neurosci. 2001; 21(1):305-13. PMC: 6762423. View

11.

Bast T, Zhang W, Heidbreder C, Feldon J . Hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine. Neuroscience. 2001; 103(2):325-35. DOI: 10.1016/s0306-4522(00)00589-3. View

12.

Millan M, Newman-Tancredi A, Quentric Y, Cussac D . The "selective" dopamine D1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors. Psychopharmacology (Berl). 2001; 156(1):58-62. DOI: 10.1007/s002130100742. View

13.

GRAHAM F . Presidential Address, 1974. The more or less startling effects of weak prestimulation. Psychophysiology. 1975; 12(3):238-48. DOI: 10.1111/j.1469-8986.1975.tb01284.x. View

14.

Geyer M, Braff D, Swerdlow N . Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl). 2001; 156(2-3):117-54. DOI: 10.1007/s002130100811. View

15.

Swerdlow N, Geyer M, Braff D . Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl). 2001; 156(2-3):194-215. DOI: 10.1007/s002130100799. View

16.

Fendt M, Li L, Yeomans J . Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology (Berl). 2001; 156(2-3):216-24. DOI: 10.1007/s002130100794. View

17.

Braff D, Geyer M, Swerdlow N . Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001; 156(2-3):234-58. DOI: 10.1007/s002130100810. View

18.

Perry W, Minassian A, Feifel D, Braff D . Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry. 2001; 50(6):418-24. DOI: 10.1016/s0006-3223(01)01184-2. View

19.

Swerdlow N, Karban B, Ploum Y, Sharp R, Geyer M, Eastvold A . Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an "fMRI-friendly" startle paradigm. Biol Psychiatry. 2001; 50(8):578-85. DOI: 10.1016/s0006-3223(01)01164-7. View

20.

LUDEWIG S, Ludewig K, Geyer M, Hell D, Vollenweider F . Prepulse inhibition deficits in patients with panic disorder. Depress Anxiety. 2002; 15(2):55-60. DOI: 10.1002/da.10026. View